欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-VWF mAbs

简要描述:

The NMC-4 antibody binds the GP1b-α binding site on the A1 domain of human von Willebrand factor (also know as vWF or Factor VIII related antigen). vWF is a plasma glycoprotein (GP) that circulates in blood as a series of multimers, in association with factor VIII procoagulant protein. It is produced by endothelial cells and megakaryocytes and is involved in the process of hemostasis by engaging in adhesion of platelets to the sites of vascular injury. Mutations in this gene lead to Von Willebrand‘s disease which causes frequent bleeding.

产品参数:

Cat. No.:MABL-3231

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:inhibit, IP, ELISA

详细介绍

Key features and   details


Cat. No.

MABL-3231

Name

Anti-VWF mAbs

Clone No.

AFD- NMC-4

From

Recombinant Antibody

Isotype

Engineer antibody

Application

inhibit, IP, ELISA

Species Reactivity

Human

Basic Information


Specificity

The NMC-4 antibody binds the GP1b-α binding site on the A1 domain of human von Willebrand factor (also know as vWF or Factor VIII related antigen). vWF is a plasma glycoprotein (GP) that circulates in   blood as a series of multimers, in association with factor VIII procoagulant protein. It is produced by endothelial cells and megakaryocytes and is involved in the process of hemostasis by engaging in adhesion of platelets to the sites of vascular injury. Mutations in this gene lead to Von Willebrand's   disease which causes frequent bleeding.

Alternative Name

F8VWF; von Willebrand Factor; von Willebrand   antigen 2; von Willebrand antigen II; Factor VIII related antigen; NMC4

UniProt

P04275

Immunogen

The original antibody was generated by immunization of BALB/C mice with FVIII/vWF fraction and fusion of spleen   cells with NS-1 murine myeloma cells.

Application Notes

The binding characterization of this   antibody was done using ELISA (Shima et al, 1985). This antibody was used in   the initial characterization of the three distinct functional sites on the von Willebrand factor molecule (PMID: 2477370). This antibody can be used for   the immunoprecipitation of the von Willebrand factor from a sample (PMID:   7679102). A study reported that this antibody was shown to inhibit its   binding to GP Ib, completely abolished SIPA (sheer induced platelet  aggregation) under high shear force, even in the presence of epinephrine.   However, this antibody only partially inhibited SIPA under low shear force   (PMID: 1360339). This antibody is also reported to completely inhibit vWF binding to platelet glycoprotein (GP) lb induced by either ristocetin or   botrocetin at an IgG concentration of approximately 10 micrograms/mL, and also blocked binding of asialo-vWF to GP lb (PMID: 1984791).

Antibody First   Published

Shima et al. Production and characterization of monoclonal antibodies against von Willebrand factor (vWF). J. Nura Med.  Assoc. (1985), 36,662-669.

Note on publication

Describes the study on various inhibitory actions of this antibody.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified   antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity   purified

Buffer

PBS with 0.02% Proclin   300.

Concentration

1 mg/ml.

Storage   Recommendation

Store at 4⁰C for up to 3   months. For longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-vWF mAbs

下一篇: Anti-VWFpp mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号